Literature DB >> 8643634

OB protein binds specifically to the choroid plexus of mice and rats.

R Devos1, J G Richards, L A Campfield, L A Tartaglia, Y Guisez, J van der Heyden, J Travernier, G Plaetinck, P Burn.   

Abstract

Binding studies were conducted to identify the anatomical location of brain target sites for OB protein, the ob gene product. 125I-labeled recombinant mouse OB protein or alkaline phosphatase-OB fusion proteins were used for in vitro and in vivo binding studies. Coronal brain sections or fresh tissue from lean, obese ob/ob, and obese db/db mice as well as lean and obese Zucker rats were probed to identify potential central OB protein-binding sites. We report here that recombinant OB protein binds specifically to the choroid plexus. The binding of OB protein (either radiolabeled or the alkaline phosphatase-OB fusion protein) and its displacement by unlabeled OB protein was similar in lean, obese ob/ob, and obese db/db mice as well as lean and obese Zucker rats. These findings suggest that OB protein binds with high affinity to a specific receptor in the choroid plexus. After binding to the choroid plexus receptor, OB protein may then be transported across the blood-brain barrier into the cerebrospinal fluid. Alternatively, binding of OB protein to a specific receptor in the choroid plexus may activate afferent neural inputs to the neural network that regulates feeding behavior and energy balance or may result in the clearance or degradation of OB protein. The identification of the choroid plexus as a brain binding site for OB protein will provide the basis for the construction of expression libraries and facilitate the rapid cloning of the choroid plexus OB receptor.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8643634      PMCID: PMC39306          DOI: 10.1073/pnas.93.11.5668

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

Review 1.  Metabolic factors in the control of energy stores.

Authors:  G A Bray; L A Campfield
Journal:  Metabolism       Date:  1975-01       Impact factor: 8.694

2.  Obese, a new mutation in the house mouse.

Authors:  A M INGALLS; M M DICKIE; G D SNELL
Journal:  J Hered       Date:  1950-12       Impact factor: 2.645

3.  Physiological regulation of body weight and the issue of obesity.

Authors:  R E Keesey
Journal:  Med Clin North Am       Date:  1989-01       Impact factor: 5.456

Review 4.  Hypothalamic and genetic obesity in experimental animals: an autonomic and endocrine hypothesis.

Authors:  G A Bray; D A York
Journal:  Physiol Rev       Date:  1979-07       Impact factor: 37.312

5.  Effects of parabiosis of obese with diabetes and normal mice.

Authors:  D L Coleman
Journal:  Diabetologia       Date:  1973-08       Impact factor: 10.122

6.  Genetically transmitted obesity in rodents.

Authors:  G A Bray; D A York
Journal:  Physiol Rev       Date:  1971-07       Impact factor: 37.312

7.  Evidence for separate receptors for insulin and insulin-like growth factor-I in choroid plexus of rat brain by quantitative autoradiography.

Authors:  D A Davidson; N J Bohannon; E S Corp; D P Lattemann; S C Woods; D Porte; D M Dorsa; D G Baskin
Journal:  J Histochem Cytochem       Date:  1990-09       Impact factor: 2.479

8.  Inherited obesity-diabetes syndromes in the mouse.

Authors:  D L Coleman
Journal:  Prog Clin Biol Res       Date:  1981

9.  Laboratory animals exhibiting obesity and diabetes syndromes.

Authors:  L Herberg; D L Coleman
Journal:  Metabolism       Date:  1977-01       Impact factor: 8.694

10.  Familial dependence of the resting metabolic rate.

Authors:  C Bogardus; S Lillioja; E Ravussin; W Abbott; J K Zawadzki; A Young; W C Knowler; R Jacobowitz; P P Moll
Journal:  N Engl J Med       Date:  1986-07-10       Impact factor: 91.245

View more
  18 in total

1.  Myosin-1c interacts with hair-cell receptors through its calmodulin-binding IQ domains.

Authors:  Janet L Cyr; Rachel A Dumont; Peter G Gillespie
Journal:  J Neurosci       Date:  2002-04-01       Impact factor: 6.167

Review 2.  Leptin signalling pathways in hypothalamic neurons.

Authors:  Obin Kwon; Ki Woo Kim; Min-Seon Kim
Journal:  Cell Mol Life Sci       Date:  2016-01-19       Impact factor: 9.261

3.  In vitro methionine oxidation of recombinant human leptin.

Authors:  J L Liu; K V Lu; T Eris; V Katta; K R Westcott; L O Narhi; H S Lu
Journal:  Pharm Res       Date:  1998-04       Impact factor: 4.200

4.  Constitutive and impaired signaling of leptin receptors containing the Gln --> Pro extracellular domain fatty mutation.

Authors:  D W White; D W Wang; S C Chua; J P Morgenstern; R L Leibel; H Baumann; L A Tartaglia
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

5.  Synergistic interaction between leptin and cholecystokinin to reduce short-term food intake in lean mice.

Authors:  M D Barrachina; V Martínez; L Wang; J Y Wei; Y Taché
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

Review 6.  The melanocortin pathway and control of appetite-progress and therapeutic implications.

Authors:  Giulia Baldini; Kevin D Phelan
Journal:  J Endocrinol       Date:  2019-04-01       Impact factor: 4.286

7.  Alteration of the leptin network in late morbid obesity induced in mice by brain infection with canine distemper virus.

Authors:  A Bernard; R Cohen; S T Khuth; B Vedrine; O Verlaeten; H Akaoka; P Giraudon; M F Belin
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

8.  Phenotypic effects of an induced mutation of the ObRa isoform of the leptin receptor.

Authors:  Zhiying Li; Giovanni Ceccarini; Michael Eisenstein; Keith Tan; Jeffrey Michael Friedman
Journal:  Mol Metab       Date:  2013-08-04       Impact factor: 7.422

9.  A cholecystokinin-1 receptor agonist (CCK-8) mediates increased permeability of brain barriers to leptin.

Authors:  V Cano; B Merino; L Ezquerra; B Somoza; M Ruiz-Gayo
Journal:  Br J Pharmacol       Date:  2008-04-21       Impact factor: 8.739

10.  The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss.

Authors:  Anna Secher; Jacob Jelsing; Arian F Baquero; Jacob Hecksher-Sørensen; Michael A Cowley; Louise S Dalbøge; Gitte Hansen; Kevin L Grove; Charles Pyke; Kirsten Raun; Lauge Schäffer; Mads Tang-Christensen; Saurabh Verma; Brent M Witgen; Niels Vrang; Lotte Bjerre Knudsen
Journal:  J Clin Invest       Date:  2014-09-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.